Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

ClinicalTrials.gov ID: NCT05619692

Public ClinicalTrials.gov record NCT05619692. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease

Study identification

NCT ID
NCT05619692
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
174 participants

Conditions and interventions

Interventions

  • SAGE-718 Drug
  • SAGE-718-matching Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2022
Primary completion
Jun 4, 2024
Completion
Jul 8, 2024
Last update posted
Sep 14, 2025

2022 – 2024

United States locations

U.S. sites
37
U.S. states
19
U.S. cities
37
Facility City State ZIP Site status
Sage Investigational Site Gilbert Arizona 85297
Sage Investigational Site Phoenix Arizona 85297
Sage Investigational Site Lafayette California 94549
Sage Investigational Site Long Beach California 90808
Sage Investigational Site Redlands California 92374
Sage Investigational Site San Diego California 92123
Sage Investigational Site Sherman Oaks California 91403
Sage Investigational Site Englewood Colorado 80120
Sage Investigational Site Hollywood Florida 33024
Sage Investigational Site Jacksonville Florida 32256
Sage Investigational Site Miami Florida 33155
Sage Investigational Site Palm Beach Gardens Florida 33410
Sage Investigational Site Pensacola Florida 32504
Sage Investigational Site Tampa Florida 33609
Sage Investigational Site Winter Park Florida 32789
Sage Investigational Site Decatur Georgia 30030
Sage Investigational Site Savannah Georgia 31404
Sage Investigational Site Honolulu Hawaii 96817
Sage Investigational Site Meridian Idaho 83642
Sage Investigational Site Chicago Illinois 60640
Sage Investigational Site Charlestown Massachusetts 02129
Sage Investigational Site Methuen Massachusetts 01844
Sage Investigational Site Chesterfield Missouri 63005
Sage Investigational Site Papillion Nebraska 68046
Sage Investigational Site Toms River New Jersey 08755
Sage Investigational Site Albuquerque New Mexico 87109
Sage Investigational Site Brooklyn New York 11229
Sage Investigational Site Buffalo New York 14203
Sage Investigational Site Staten Island New York 10312
Sage Investigational Site Raleigh North Carolina 27607
Sage Investigational Site Abington Pennsylvania 19001
Sage Investigational Site Memphis Tennessee 38119
Sage Investigational Site Nashville Tennessee 37212
Sage Investigational Site Austin Texas 78731
Sage Investigational Site Dallas Texas 75231
Sage Investigational Site Houston Texas 77030
Sage Investigational Site Fairfax Virginia 22031

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05619692, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 14, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05619692 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →